Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

Related Citations for PubMed (Select 20972721)

1.

Expression and somatic mutations of SDHAF2 (SDH5), a novel endocrine tumor suppressor gene in parathyroid tumors of primary hyperparathyroidism.

Starker LF, Delgado-Verdugo A, Udelsman R, Björklund P, Carling T.

Endocrine. 2010 Dec;38(3):397-401. doi: 10.1007/s12020-010-9399-0. Epub 2010 Oct 23.

PMID:
20972721
2.

Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.

Scarpelli D, D'Aloiso L, Arturi F, Scillitani A, Presta I, Bisceglia M, Cristofaro C, Russo D, Filetti S.

J Endocrinol Invest. 2004 Dec;27(11):1015-21.

PMID:
15754732
3.

Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.

Karges W, Jostarndt K, Maier S, Flemming A, Weitz M, Wissmann A, Feldmann B, Dralle H, Wagner P, Boehm BO.

J Endocrinol. 2000 Jul;166(1):1-9.

4.

Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.

Dwight T, Twigg S, Delbridge L, Wong FK, Farnebo F, Richardson AL, Nelson A, Zedenius J, Philips J, Larsson C, Teh BT, Robinson B.

Clin Endocrinol (Oxf). 2000 Jul;53(1):85-92.

PMID:
10931084
5.

Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.

Miedlich S, Krohn K, Lamesch P, Müller A, Paschke R.

Eur J Endocrinol. 2000 Jul;143(1):47-54.

6.

Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.

Evans CO, Brown MR, Parks JS, Oyesiku NM.

J Endocrinol Invest. 2000 May;23(5):304-9.

PMID:
10882148
7.

Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.

Uchino S, Noguchi S, Sato M, Yamashita H, Yamashita H, Watanabe S, Murakami T, Toda M, Ohshima A, Futata T, Mizukoshi T, Koike E, Takatsu K, Terao K, Wakiya S, Nagatomo M, Adachi M.

Cancer Res. 2000 Oct 1;60(19):5553-7.

8.
9.

MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.

Cetani F, Pardi E, Vignali E, Borsari S, Picone A, Cianferotti L, Ambrogini E, Miccoli P, Pinchera A, Marcocci C.

J Endocrinol Invest. 2002 Jun;25(6):508-12.

PMID:
12109621
10.

Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.

Bergman L, Boothroyd C, Palmer J, Grimmond S, Walters M, Teh B, Shepherd J, Hartley L, Hayward N.

Br J Cancer. 2000 Oct;83(8):1003-8.

11.

Molecular pathogenesis of primary hyperparathyroidism.

Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, Wild Y, Saucier K.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N30-6. Review.

PMID:
12412775
12.

Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.

Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Skarulis MC, James LA, Goldsmith PK, Saggar SK, Park SY, Spiegel AM, Burns AL, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Emmert-Buck MR, Guru SC, Manickam P, Crabtree J, Erdos MR, Collins FS, Chandrasekharappa SC.

Recent Prog Horm Res. 1999;54:397-438; discussion 438-9. Review.

PMID:
10548885
13.

Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas.

Samander EH, Arnold A.

J Clin Endocrinol Metab. 2006 Dec;91(12):5019-21. Epub 2006 Sep 26.

PMID:
17003089
14.

Mutational analysis of CDKN1B, a candidate tumor-suppressor gene, in refractory secondary/tertiary hyperparathyroidism.

Lauter KB, Arnold A.

Kidney Int. 2008 May;73(10):1137-40. doi: 10.1038/ki.2008.28. Epub 2008 Feb 20.

PMID:
18288099
15.

Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.

Mizusawa N, Uchino S, Iwata T, Tsuyuguchi M, Suzuki Y, Mizukoshi T, Yamashita Y, Sakurai A, Suzuki S, Beniko M, Tahara H, Fujisawa M, Kamata N, Fujisawa K, Yashiro T, Nagao D, Golam HM, Sano T, Noguchi S, Yoshimoto K.

Clin Endocrinol (Oxf). 2006 Jul;65(1):9-16.

PMID:
16817812
16.

Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.

Shattuck TM, Välimäki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A.

N Engl J Med. 2003 Oct 30;349(18):1722-9.

17.

Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.

Newey PJ, Nesbit MA, Rimmer AJ, Attar M, Head RT, Christie PT, Gorvin CM, Stechman M, Gregory L, Mihai R, Sadler G, McVean G, Buck D, Thakker RV.

J Clin Endocrinol Metab. 2012 Oct;97(10):E1995-2005. doi: 10.1210/jc.2012-2303. Epub 2012 Aug 1.

PMID:
22855342
18.

Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.

Carling T, Correa P, Hessman O, Hedberg J, Skogseid B, Lindberg D, Rastad J, Westin G, Akerström G.

J Clin Endocrinol Metab. 1998 Aug;83(8):2960-3.

PMID:
9709976
19.

Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.

Vierimaa O, Villablanca A, Alimov A, Georgitsi M, Raitila A, Vahteristo P, Larsson C, Ruokonen A, Eloranta E, Ebeling TM, Ignatius J, Aaltonen LA, Leisti J, Salmela PI.

J Endocrinol Invest. 2009 Jun;32(6):512-8. doi: 10.3275/6107. Epub 2009 Mar 26.

PMID:
19474519
20.

Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.

Farnebo F, Teh BT, Dotzenrath C, Wassif WS, Svensson A, White I, Betz R, Goretzki P, Sandelin K, Farnebo LO, Larsson C.

Hum Genet. 1997 Mar;99(3):342-9.

PMID:
9050920
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk